In an embodiment, the third compound may be a compound represented by one of Formulae 4-1(1), 4-1(2), 4-2(1) to 4-2(4), and 4-3(1):
In Formulae 4-1(1), 4-1(2), 4-2(1) to 4-2(4), and 4-3(1),
In Formulae 1, 2, 3-1 to 3-4, and 4-1 to 4-3, L1 to L4, L61, L71 to L73, L81 to L87, and L91 to L94 may each independently be a single bond, a C5-C30 carbocyclic group unsubstituted or substituted with at least one R10a, or a C1-C30 heterocyclic group unsubstituted or substituted with at least one R10a.